Cover Image
市場調查報告書

MediPoint:MRI(核磁共振成像)設備--亞太地區市場分析與預測

MediPoint: Magnetic Resonance Imaging Systems - APAC Analysis and Market Forecasts

出版商 GlobalData 商品編碼 322143
出版日期 內容資訊 英文 167 Pages
訂單完成後即時交付
價格
Back to Top
MediPoint:MRI(核磁共振成像)設備--亞太地區市場分析與預測 MediPoint: Magnetic Resonance Imaging Systems - APAC Analysis and Market Forecasts
出版日期: 2014年12月31日 內容資訊: 英文 167 Pages
簡介

全球MRI(核磁共振成像)市場正處於變革期,特別是資本設備市場已達飽和狀態,多數企業正在開發新產品。另一方面,MRI自出現以來,由於其高度安全性及非侵入式受到高度評價,引進規模正在持續擴大。影像技術的急速進步及安全技術的發展,都關係到潛在性治療對象領域的擴大。日本方面,預測所有領域產品未來市場都將成長,即使是其他國家市場規模縮小的低磁場MRI也一樣成長。中國所有部門都將成長,但預測低磁場MRI年平均成長率將會滯留於(CAGR)1%。印度預測低磁場MRI則有CAGR負0.6%這樣的微減傾向。

本報告提供亞太地區各國的核磁共振成像(以下簡稱MRI)設備市場相關分析,提供您設備的技術性特性和市場結構,目前未滿足需求,主要的推動及阻礙市場要素,今後的市場機會,現在正在開發的主要產品,地區整體及主要國家的市場趨勢(過去3年的實際成果值今後7年的預測值),各類型產品的詳細趨勢,主要企業簡介等調查。

第1章 目錄

第2章 簡介

第3章 產業概要

  • 核磁共振攝影技術概要
  • 系統概要
    • 預磁化場核磁共振攝影系統
    • 擴散核磁共振攝影
    • 表觀擴散係數
  • 技術的應用領域
  • 核磁共振攝影檢查之臨床上的適應範圍
  • 治療趨勢
    • 產品的生命週期
  • 技術的優點·缺點
    • 概要
    • 核磁共振攝影技術的SWOT分析
    • 核磁共振造影系統方面的幽閉恐懼症問題
    • 磁振造影(核磁共振攝影) vs. 電腦斷層攝影(CT)
  • 打入市場
    • 產品的生命週期
    • 購買意願決策
    • 團購組織所扮演的角色
  • 法規流程
  • 目前核磁共振攝影的醫療費給付趨勢
  • 治療趨勢
    • 神經學
    • 四肢核磁共振攝影
    • PET/MRI
    • 亞太地區
    • 磁共振血管造影術
    • 磁共振頻譜檢測
    • 運用時間
    • 法規上的課題/回收
  • 經濟影響
    • 直接的費用
    • 核磁共振攝影系統的價格

第4章 未滿足需求

  • 概要
  • 實驗對象資料的保管·管理
  • 多參數核磁共振攝影
  • 帶給實驗對象高舒適性,高靜肅性的系統
  • 改善支援高畫質影像硬體用軟體
  • 容許量的高速化
  • 改善實驗對象的舒適性

第5章 市場機會分析

  • 概要
  • 掃描的標準化
  • 各種醫院引進MRI件數的擴大
  • 心臟用核磁共振攝影的普及
  • 腦發達研究的高磁場核磁共振攝影
  • 電力供給不穩定狀態下仍維持效能的永久磁石
  • 腦瘤的影像化
  • 無冷凍劑的冷卻系統
  • 門診病人檢驗用的追加掃描儀
  • 乳癌·前列腺癌症用核磁共振攝影
  • 癌症全身核磁共振攝影
  • 雲端運算的發達
  • 為了加快腦外傷的診斷速度的新技術

第6章 推動市場要素及障礙

  • 概要
  • 推動因素:改善更高磁場的影像取得能力
  • 推動因素:老化設備的低畫品質影像
  • 推動因素:核磁共振造影系統平均年齡老舊
  • 推動因素:老化設備難以取得同質訊號
  • 障礙:機器操作訓練用資源不足
  • 障礙:經濟壓力造成新設備引進規模縮小
  • 障礙:系統的誤用
  • 障礙:核磁共振攝影系統的任意驅使
  • 障礙:ISO(獨立型服務組織):廠商的服務·新產品銷售代替的價錢比較便宜的替代方式
  • 障礙:超導性核磁共振攝影磁鐵廠商
  • 障礙:核磁共振攝影治療的醫療費給付額不一

第7章 競爭評估

  • 主要產品的完全簡介
    • Oasis (日立Medical)
    • Echelon Oval (日立Medical)
    • Discovery MR750w (GE Healthcare)
    • Optima MR360 Advance (GE Healthcare)
    • Optima MR450w (GE Healthcare)
    • Signa HDxt (GE Healthcare)
    • Vantage Titen (Philips Healthcare)
    • Ingenia (Philips Healthcare)
    • Achieva TX (Philips Healthcare)
    • Magnetom Aera (Siemens Healthcare)
    • Magnetom C! (Siemens Healthcare)
    • Magnetom Spectra (Siemens Healthcare)
    • NSM-S15 (Neusoft Medical Systems)
  • 基於磁力強度的分類
    • 低磁場核磁共振造影系統
    • 中磁場核磁共振造影系統
    • 高磁場核磁共振造影系統

第8章 開發平台評估

  • 11.7T MRI Sytem (Neurospin)
  • Aurora PET/MRI System (Aurora Imaging Technology)
  • Neona (Time Medical)
  • GE 7.0T MRI Scanner (GE Healthcare)
  • Signa PET/MRI (GE Healthcare)

第9章 現在及未來的主要企業

  • 概要
  • Aurora Imaging
  • China Resources Wandong Medical Equipment
  • Esaote S.p.A.
  • Fonar Corporation
  • GE Healthcare
  • 日立Medical
  • Hologic
  • Mindray
  • Neusoft Medical
  • Ningbo Xingaoyi Medical
  • Philips Healthcare
  • Siemens Healthcare
  • Time Medical
  • 東芝MedicalSystems

第10章 策略性的競爭評估

  • 各企業的市場佔有率

第11章 市場展望:各市場區隔

  • 各國市場明細

第12章 市場展望:各地區

  • APAC(亞太地區)
    • APAC的市場佔有率:各國
    • APAC市場規模:各市場區隔
  • 日本
  • 中國
  • 印度

第13章 附錄

圖表一覽

目錄
Product Code: GDME1123CFR

The global magnetic resonance imaging (MRI) market is a shifting, capital equipment market that is saturated with numerous players developing innovative technologies. Given their impressive safety and efficacy as well as non-invasive nature, MRI systems have seen continued adoption since they were first introduced to the healthcare market. Rapid advances in the field imaging along with the development of MRI safe technologies have greatly expanded the potential of therapeutic applications.

All MRI markets in Japan are expected to experience growth through 2020, including low-field systems, which are declining in many other countries globally. All MRI market segments will experience growth in China during the forecast period, although low-field systems will grow at a small CAGR of 1.0%. In India, the low-field strength MRI market segment will decline slightly at a negative CAGR of 0.6% through 2020,

Scope

  • An overview of Magnetic Resonance Imaging Systems, which includes epidemiology, etiology, symptoms, diagnosis, pathology and treatment guidelines.
  • Annualized the APAC Magnetic Resonance Imaging Systems market revenue and future forecasts from 2011 to 2013, forecast for 7 years to 2020.
  • Investigation of current and future market competition for Magnetic Resonance Imaging Systems.
  • Insightful review of the key industry drivers, restraints and challenges as well as predicted impact of key events.
  • Competitor assessment including device approval analysis and device sales forecasts.
  • Marketed and pipeline product profiles covering efficiency, safety, clinical study details, device approvals, product positioning and device sales forecast.
  • Analysis of unmet needs within the market and opportunities for future players.
  • Technology trends evaluation to assess strength of pipeline.
  • An overview of all devices in development including clinical study details, design and material selection considerations, efficacy reports, and device approval timelines.
  • Company profiles including business description, financial overview and SWOT analysis.
  • Coverage of key market players.
  • Strategic assessment of the Magnetic Resonance Imaging Systems sector through market impact analysis, future market scenario and company analysis.
  • Direct quotes from Key Opinion Leaders (KOL) as well as doctors

Reasons to buy

  • Understand the trends shaping and driving the APAC Magnetic Resonance Imaging Systems market.
  • Realize device preferences of physicians who have performed the tests already.
  • Access market sizing, forecasts and quantified growth opportunities in the APAC Magnetic Resonance Imaging Systems market through 2018.
  • Quantify candidate patient populations to better design product pricing & launch plans.
  • Drive revenues, formulate effective sales and marketing strategies and gain in-depth understanding of the competitive landscape.
  • Perform benchmarking analysis of growth opportunities against currently marketed products.
  • Assess competitiveness of products in market by understanding the strengths and weaknesses of current competition.
  • Take a comprehensive look at the market's device pipeline and identify promising, paradigm-shifting products.
  • Create an effective counter-strategy to gain a competitive advantage against those currently in the market.
  • Organize your sales and marketing efforts by identifying the market categories and segments that present the best opportunities for growth.
  • What's the next big thing in the APAC Magnetic Resonance Imaging Systems market landscape? Identify, understand and capitalize.

Table of Contents

1. Table of Contents

  • 1.1. List of Tables
  • 1.2. List of Figures

2. Introduction

  • 2.1. Catalyst
  • 2.2. Related Reports

3. Industry Overview

  • 3.1. Overview of MRI Technology
  • 3.2. System Overview
    • 3.2.1. Pre-Polarizing MRI Systems
    • 3.2.2. Diffusion MRI
    • 3.2.3. Apparent Diffusion Coefficient
  • 3.3. Applications of Technology
  • 3.4. Clinical Indications for MRI scans
  • 3.5. Procedure Trends
    • 3.5.1. Product Lifecycle
  • 3.6. Advantages and Disadvantages of Technology
    • 3.6.1. Overview
    • 3.6.2. MRI Technology SWOT Analysis
    • 3.6.3. Claustrophobia Issues with MRI Systems
    • 3.6.4. Magnetic Resonance Imaging vs. Computed Tomography
  • 3.7. Market Access
    • 3.7.1. Product Life Cycle
    • 3.7.2. Purchasing Decisions
    • 3.7.3. Role of Group Purchasing Organizations
  • 3.8. Regulatory Process
    • 3.8.1. Japan
    • 3.8.2. China
    • 3.8.3. India
  • 3.9. Current MRI Reimbursement Trends
    • 3.9.1. Japan
    • 3.9.2. China
    • 3.9.3. India
  • 3.10. Procedure Trends
    • 3.10.1. Neurology
    • 3.10.2. Extremity MRI
    • 3.10.3. PET/MRI
    • 3.10.4. Asia-Pacific
    • 3.10.5. Magnetic Resonance Angiography
    • 3.10.6. Magnetic Resonance Spectroscopy
    • 3.10.7. Hours of Operation
    • 3.10.8. Regulatory Issues/Recalls
  • 3.11. Economic Impact
    • 3.11.1. Direct Costs
    • 3.11.2. Pricing of MRI Systems

4. Unmet Needs

  • 4.1. Overview
  • 4.2. Storing and Managing Patient Data
  • 4.3. Multiparametric MRI
  • 4.4. Quieter Systems for Improved Patient Comfort
  • 4.5. Improved Software to Support Advanced Image Acquisition Hardware
  • 4.6. Faster Throughput
  • 4.7. Improvements in Patient Comfort

5. Market Opportunity Analysis

  • 5.1. Overview
  • 5.2. Standardization of Scans
  • 5.3. Increased Adoption of MRI Throughout the Hospital
  • 5.4. Cardiac MRI on the Rise
  • 5.5. High-Field MRI in Developing Brains
  • 5.6. Permanent Magnets Still Desirable Where Power Unreliable
  • 5.7. Imaging Brain Tumors
  • 5.8. Cryogen-Free Cooling Systems
  • 5.9. Additional Scanners for Outpatient Exams
  • 5.10. Breast and Prostate Cancer MRI
  • 5.11. Whole-Body MRI for Cancer
  • 5.12. Cloud Computing on the Rise
  • 5.13. New MRI Technique to Speed Up Diagnosis for Traumatic Brain Injury

6. Market Drivers and Barriers

  • 6.1. Overview
  • 6.2. Driver: Improved Imaging Capabilities of Higher Field Strength
  • 6.3. Driver: Low-Quality Images from Older Machines
  • 6.4. Driver: High Average Age of MRI Systems
  • 6.5. Driver: Difficulty of Achieving Homogenous Signals with Older Systems
  • 6.6. Barrier: Fewer Resources for Training on Machines
  • 6.7. Barrier: Economic Pressure Reduces New Systems Volume
  • 6.8. Barrier: Misuse of Systems
  • 6.9. Barrier: Overuse of MRI Systems
  • 6.10. Barrier: ISOs a Cheaper Alternative to Service or New Sales from OEM
  • 6.11. Barrier: Supeconducting MRI Magnet Producers
  • 6.12. Barrier: Uneven Reimbursement for MRI Procedures

7. Competitive Assessment

  • 7.1. Full Profiles for Key Products
    • 7.1.1. Oasis (Hitachi)
    • 7.1.2. Echelon Oval (Hitachi)
    • 7.1.3. Discovery MR750w (GE Healthcare)
    • 7.1.4. Optima MR360 Advance (GE Healthcare)
    • 7.1.5. Optima MR450w (GE Healthcare)
    • 7.1.6. Signa HDxt (GE Healthcare)
    • 7.1.7. Vantage Titen (Philips Healthcare)
    • 7.1.8. Ingenia (Philips Healthcare)
    • 7.1.9. Achieva TX (Philips Healthcare)
    • 7.1.10. Magnetom Aera (Siemens Healthcare)
    • 7.1.11. Magnetom C! (Siemens Healthcare)
    • 7.1.12. Magnetom Spectra (Siemens Healthcare)
    • 7.1.13. NSM-S15 (Neusoft Medical Systems)
  • 7.2. Classification Based on Field Strength
    • 7.2.1. Low-Field MRI Systems
    • 7.2.2. Mid-Field MRI Systems
    • 7.2.3. High-Field MRI Systems

8. Pipeline Assessment

  • 8.1. 11.7T MRI System (Neurospin)
    • 8.1.1. Overview
    • 8.1.2. SWOT
  • 8.2. Aurora PET/MRI System (Aurora Imaging Technology)
    • 8.2.1. Overview
    • 8.2.2. SWOT
  • 8.3. Neona (Time Medical)
    • 8.3.1. Overview
    • 8.3.2. SWOT
  • 8.4. GE 7.0T MRI Scanner (GE Healthcare)
    • 8.4.1. Overview
    • 8.4.2. SWOT
  • 8.5. Signa PET/MRI (GE Healthcare)
    • 8.5.1. Overview
    • 8.5.2. SWOT

9. Current and Future Players

  • 9.1. Overview
  • 9.2. Aurora Imaging
    • 9.2.1. Overview
    • 9.2.2. Portfolio Assessment

9.2.3. SWOT Analysis

  • 9.3. China Resources Wandong Medical Equipment
    • 9.3.1. Overview
    • 9.3.2. Portfolio Assessment
    • 9.3.3. SWOT Analysis
  • 9.4. Esaote S.p.A.
    • 9.4.1. Overview
    • 9.4.2. Portfolio Assessment
    • 9.4.3. SWOT Analysis
  • 9.5. Fonar Corporation
    • 9.5.1. Overview
    • 9.5.2. Portfolio Assessment
    • 9.5.3. SWOT Analysis
  • 9.6. GE Healthcare
    • 9.6.1. Overview
    • 9.6.2. Portfolio Assessment
    • 9.6.3. SWOT Analysis
  • 9.7. Hitachi Medical Corporation
    • 9.7.1. Overview
    • 9.7.2. Portfolio Assessment
    • 9.7.3. SWOT Analysis
  • 9.8. Hologic
    • 9.8.1. Overview
    • 9.8.2. Portfolio Assessment
    • 9.8.3. SWOT Analysis
  • 9.9. Mindray
    • 9.9.1. Overview
    • 9.9.2. Portfolio Assessment
    • 9.9.3. SWOT Analysis
  • 9.10. Neusoft Medical
    • 9.10.1. Overview
    • 9.10.2. Portfolio Assessment
    • 9.10.3. SWOT Analysis
  • 9.11. Ningbo Xingaoyi Medical
    • 9.11.1. Overview
    • 9.11.2. Portfolio Assessment
    • 9.11.3. SWOT Analysis
  • 9.12. Philips Healthcare
    • 9.12.1. Overview
    • 9.12.2. Portfolio Assessment
    • 9.12.3. SWOT Analysis
  • 9.13. Siemens Healthcare
    • 9.13.1. Overview
    • 9.13.2. Portfolio Assessment
    • 9.13.3. SWOT Analysis
  • 9.14. Sina Healthcare
    • 9.14.1. Overview
    • 9.14.2. Portfolio Assessment
    • 9.14.3. SWOT Analysis
  • 9.15. Time Medical
    • 9.15.1. Overview
    • 9.15.2. Portfolio Assessment
    • 9.15.3. SWOT Analysis
  • 9.16. Toshiba Medical Systems Corporation
    • 9.16.1. Overview
    • 9.16.2. Portfolio Assessment
    • 9.16.3. SWOT Analysis

10. Stategic Competitive Assessment

  • 10.1. Company Market Share
    • 10.1.1. APAC
    • 10.1.2. Japan
    • 10.1.3. China
    • 10.1.4. India

11. Market Outlooks by Market Segment

  • 11.1. Market Segment by Country
    • 11.1.1. Japan
    • 11.1.2. China
    • 11.1.3. India

12. Market Outlooks by Geography

  • 12.1. APAC
    • 12.1.1. APAC Market Share by Country
    • 12.1.2. APAC Market Value by Market Segment
  • 12.2. Japan
    • 12.2.1. Market Value by Market Segment
    • 12.2.2. Installed Base of MRI Systems
  • 12.3. China
    • 12.3.1. Market Value by Market Segment
    • 12.3.2. Installed Base of MRI Systems
  • 12.4. India
    • 12.4.1. Market Value by Market Segment
    • 12.4.2. Installed Base of MRI Systems

13. Appendix

  • 13.1. Bibliography
  • 13.2. Abbreviations
  • 13.3. Report Methodology
    • 13.3.1. Overview
    • 13.3.2. Coverage
    • 13.3.3. Secondary Research
  • 13.4. Forecasting Methodology
  • 13.5. Primary Research - Key Opinion Leaders
  • 13.6. Primary Research - Physician and Industry Overviews
    • 13.6.1. Expert Panel Validation
  • 13.7. Physicians & Experts Included in this Study
  • 13.8. About the Authors
    • 13.8.1. Analysts
    • 13.8.2. Global Head of Healthcare
  • 13.9. About MediPoint
  • 13.10. About GlobalData
  • 13.11. Disclaimer

List of Tables

  • Table 1: MRI Procedure Targets
  • Table 2: Indications for an Immediate Emergency MRI
  • Table 3: Advantages and Disadvantages of MRI
  • Table 4: Magnetic Resonance Imaging Technology SWOT Analysis
  • Table 5: Selected Group Purchasing Organizations in the US and EU
  • Table 6: Japan Average Selling Price by Market Segment (2011-2020), $m
  • Table 7: China Average Selling Price by Market Segment (2011-2020), $m
  • Table 8: India Average Selling Price by Market Segment (2011-2020), $m
  • Table 9: MRI Applications and Future Market Potential
  • Table 10: SWOT Analysis - Oasis
  • Table 11: SWOT Analysis - Echelon Oval
  • Table 12: SWOT Analysis - Discovery MR750w
  • Table 13: SWOT Analysis - Optima MR360 Advance
  • Table 14: SWOT Analysis - Optima MR450w
  • Table 15: SWOT Analysis - Signa HDxt
  • Table 16: SWOT Analysis - Vantage Titen
  • Table 17: SWOT Analysis - Ingenia
  • Table 18: SWOT Analysis - Achieva TX
  • Table 19: SWOT Analysis - Magnetom Aera
  • Table 20: SWOT Analysis - Magnetom C!
  • Table 21: SWOT Analysis - Magnetom Spectra
  • Table 22: SWOT Analysis - NSM-S15
  • Table 23: SWOT Analysis - Low-Field MRI Systems
  • Table 24: Low-Field MRI Systems
  • Table 25: SWOT Analysis - Mid-Field MRI Systems
  • Table 26: Mid-Field MRI Systems
  • Table 27: SWOT Analysis - High-Field MRI Systems
  • Table 28: High-Field MRI Systems
  • Table 29: SWOT Analysis - 11.7T MRI (Neurospin)
  • Table 30: SWOT Analysis - Aurora PET/MRI System (Aurora Imaging Technology)
  • Table 31: SWOT Analysis - Neona (Time Medical)
  • Table 32: SWOT Analysis - 7.0T MRI Scanner (GE Healthcare)
  • Table 33: SWOT Analysis - Signa PET/MR (GE Healthcare)
  • Table 34: Company Profile - Aurora Imaging
  • Table 35: Aurora Imaging, MRI System Device Portfolio
  • Table 36: SWOT Analysis - Aurora Imaging
  • Table 37: Company Profile - China Resources Wandong Medical Equipment
  • Table 38: China Resources Wandong Medical Equipment, MRI System Device Portfolio
  • Table 39: SWOT Analysis - China Resources Wandong Medical Equipment
  • Table 40: Company Profile - Esaote S.p.A.
  • Table 41: Esaote S.p.A., MRI System Device Portfolio
  • Table 42: SWOT Analysis - Esaote S.p.A.
  • Table 43: Company Profile - Fonar Corporation
  • Table 44: Fonar Corporation, MRI System Device Portfolio
  • Table 45: SWOT Analysis - Fonar Corporation
  • Table 46: Company Profile - GE Healthcare
  • Table 47: GE Healthcare, MRI System Device Portfolio
  • Table 48: SWOT Analysis - GE Healthcare
  • Table 49: Company Profile - Hitachi Medical Corporation
  • Table 50: Hitachi Medical Corporation, MRI System Device Portfolio
  • Table 51: SWOT Analysis - Hitachi Medical
  • Table 52: Company Profile - Hologic
  • Table 53: SWOT Analysis - Hologic
  • Table 54: Company Profile - Mindray
  • Table 55: Mindray, MRI System Device Portfolio
  • Table 56: SWOT Analysis - Mindray
  • Table 57: Company Profile - Neusoft Medical
  • Table 58: Neusoft Medical, MRI System Device Portfolio
  • Table 59: SWOT Analysis - Neusoft Medical
  • Table 60: Company Profile - Ningbo Xingaoyi Medical
  • Table 61: Ningbo Xingaoyi Magnetism, MRI System Device Portfolio
  • Table 62: SWOT Analysis - Ningbo Xingaoyi Magnetism
  • Table 63: Company Profile - Philips Healthcare
  • Table 64: Philips Healthcare, MRI System Device Portfolio
  • Table 65: SWOT Analysis - Philips Healthcare
  • Table 66: Company Profile - Siemens Healthcare
  • Table 67: Siemens Healthcare, MRI System Device Portfolio
  • Table 68: SWOT Analysis - Siemens Healthcare
  • Table 69: Company Profile - Sina Healthcare
  • Table 70: Sina Healthcare, MRI System Device Portfolio
  • Table 71: SWOT Analysis - Sina Healthcare
  • Table 72: Company Profile - Time Medical
  • Table 73: Time Medical, MRI System Device Portfolio
  • Table 74: SWOT Analysis - Time Medical
  • Table 75: Company Profile - Toshiba
  • Table 76: Toshiba, MRI System Device Portfolio
  • Table 77: SWOT Analysis - Toshiba
  • Table 78: APAC Market Sales for MRI Systems (2012)
  • Table 79: Japan Market Sales for MRI Systems (2012)
  • Table 80: China Market Sales for MRI Systems (2012)
  • Table 81: India Market Sales for MRI Systems (2012)
  • Table 82: Japan Market Segment, 2012 & 2020
  • Table 83: China Market Segment, 2012 & 2020
  • Table 84: India Market Segment, 2012 & 2020
  • Table 85: APAC Market by Country, 2012 & 2020
  • Table 86: APAC Market Value by Market Segment for MRI Systems (2011-2020), $m
  • Table 87: Japan Market Value Forecast by Market Segment (2011-2020), $m
  • Table 88: Japan Installed Base of MRI Systems (2011-2020)
  • Table 89: China Market Value Forecast by Market Segment (2011-2020), $m
  • Table 90: China Installed Base of MRI Systems (2011-2020)
  • Table 91: India Market Value Forecast by Market Segment (2011-2020), $m
  • Table 92: India Installed Base of MRI Systems (2011-2020)
  • Table 93: Primary Research Interviews Completed by Country
  • Table 94: Primary Research Interviews Completed by Designation

List of Figures

  • Figure 1: Japan Average Selling Price by Market Segment
  • Figure 2: China Average Selling Price by Market Segment
  • Figure 3: India Average Selling Price by Market Segment
  • Figure 4: Average Age for Magnetic Resonance Imaging Machines in 5EU in 2013
  • Figure 5: APAC Market Share for MRI Systems (2012)
  • Figure 6: Japan Market Share for MRI Systems (2012)
  • Figure 7: China Market Share for MRI Systems (2012)
  • Figure 8: India Market Share for MRI Systems (2012)
  • Figure 9: Japan Market Segment, 2012 & 2020
  • Figure 10: China Market Segment, 2012 & 2020
  • Figure 11: India Market Segment, 2012 & 2020
  • Figure 12: APAC Market by Country, 2012 & 2020
  • Figure 13: APAC Market Value Forecast by Market Segment for MRI Systems (2011-2020), $m
  • Figure 14: Japan Market Value Forecast by Market Segment (2011-2020), $m
  • Figure 15: Japan Installed Base of MRI Systems (2011-2020)
  • Figure 16: China Market Value Forecast by Market Segment (2011-2020), $m
  • Figure 17: China Installed Base of MRI Systems (2011-2020)
  • Figure 18: India Market Value Forecast by Market Segment (2011-2020), $m
  • Figure 19: India Installed Base of MRI Systems (2011-2020)
  • Figure 20: Primary Research Interviews Completed by Country
  • Figure 21: Primary Research Interviews Completed by Designation
Back to Top